Currently, cervical cancer screening is inefficient and women-unfriendly. Every year, one million European women receive an incorrect diagnosis, meaning that expensive follow-up tests (such as colposcopy and biopsies)are unnecessarily performed in hospitals. The current test is experienced as unpleasant by women, which is why between 40-59% of the invited women do not participate in the population screening.

Cervical cancer is a disease that can almost always be prevented by adequate screening. However, current screening methods are not sufficiently accurate, which means that every year one million European women are wrongly suspected of having cervical cancer. This leads to a lot of stress, stigmatisation and unnecessary healthcare costs.

The project of CC Diagnostics has received help and funding from the Europees Fonds voor Regionale Ontwikkeling (EFRO) in collaboration with Samenwerkingsverband Noord-Nederland (SNN).